Spectrum Pharmaceuticals Stock News

LOS ANGELES--(BUSINESS WIRE)---- $SPPI #SPPI--SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc.

Boston, Massachusetts--(Newsfile Corp. - September 1, 2021) - Block & Leviton announces that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) for potential s

NEW YORK, Aug. 31, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc ("Spectrum" or the "Company") (NASDAQ: SPPI) and certai

New York, New York--(Newsfile Corp. - August 17, 2021) -  Pomerantz LLP is investigating claims on behalf of investors of Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI).

Spectrum Pharmaceuticals, Inc. (SPPI) CEO Joe Turgeon on Q2 2021 Results - Earnings Call Transcript

HENDERSON, Nev.--(BUSINESS WIRE)---- $SPPI--Spectrum Pharmaceuticals (SPPI), a biopharma company focused on novel and targeted oncology therapies, reports results for 2Q2021 and a corp update.

NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Spectrum Pharmaceuticals, Inc. (“Spectrum” or

NEW YORK, Aug. 9, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI).  Such investor

SAN DIEGO, Aug. 6, 2021 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Spectrum Pharmaceuticals, Inc. ("Spectru

Boston, Massachusetts--(Newsfile Corp. - August 6, 2021) - Block & Leviton is investigating Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) for potential securities law violations. Investors who have lo

BeyondSpring's Plinabulin: Upcoming PDUFA And Positioning In The CIN Space

Spectrum's Big Approval: Any Day Now

Investors need to pay close attention to for Spectrum Pharmaceuticals (SPPI) stock based on the movements in the options market lately.

HENDERSON, Nev.--(BUSINESS WIRE)---- $SPPI--Spectrum Pharmaceuticals (SPPI) to participate in the Jefferies and JMP Securities investor conferences in June.

Rolontis approval was delayed due to Covid-19 and the FDA's inability to inspect its Korean manufacturing facility. The FDA plans to inspect the Hanmi facility this month.